uniQure NV (QURE)
4.535
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
4.535
0.00 (0.00%)
After-Hours: 20:00
uniQure Shareholders Equity (Quarterly): 207.67M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 207.67M |
| September 30, 2023 | 268.78M |
| June 30, 2023 | 353.32M |
| March 31, 2023 | 412.77M |
| December 31, 2022 | 476.01M |
| September 30, 2022 | 421.17M |
| June 30, 2022 | 486.49M |
| March 31, 2022 | 546.00M |
| December 31, 2021 | 595.78M |
| September 30, 2021 | 590.76M |
| June 30, 2021 | 633.61M |
| March 31, 2021 | 228.69M |
| December 31, 2020 | 243.90M |
| September 30, 2020 | 227.89M |
| June 30, 2020 | 265.50M |
| March 31, 2020 | 295.15M |
| December 31, 2019 | 323.06M |
| September 30, 2019 | 350.23M |
| June 30, 2019 | 132.06M |
| March 31, 2019 | 157.11M |
| December 31, 2018 | 179.61M |
| September 30, 2018 | 199.85M |
| Date | Value |
|---|---|
| June 30, 2018 | 218.42M |
| March 31, 2018 | 100.26M |
| December 31, 2017 | 89.36M |
| September 30, 2017 | 19.61M |
| June 30, 2017 | 27.29M |
| March 31, 2017 | 45.73M |
| December 31, 2016 | 63.63M |
| September 30, 2016 | 81.20M |
| June 30, 2016 | 94.89M |
| March 31, 2016 | 114.77M |
| December 31, 2015 | 127.93M |
| September 30, 2015 | 146.79M |
| June 30, 2015 | 131.71M |
| March 31, 2015 | 36.57M |
| December 31, 2014 | 52.39M |
| September 30, 2014 | 64.97M |
| June 30, 2014 | 75.46M |
| March 31, 2014 | 85.31M |
| December 31, 2013 | 7.683M |
| September 30, 2013 | 15.28M |
| December 31, 2012 | -0.5925M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
132.06M
Minimum
Jun 2019
633.61M
Maximum
Jun 2021
371.52M
Average
350.23M
Median
Sep 2019
Shareholders Equity (Quarterly) Benchmarks
| ProQR Therapeutics NV | 45.75M |
| Merus NV | 356.34M |
| argenx SE | 4.098B |
| Pharming Group | 218.78M |
| Pharvaris NV | 424.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 831.69M |
| Total Liabilities (Quarterly) | 624.02M |
| Debt to Equity Ratio | 0.49 |
| Current Ratio | 8.848 |
| Net Debt Paydown Yield | 0.04% |